226 related articles for article (PubMed ID: 6812131)
1. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
Riffee WH; Wilcox RE; Vaughn DM; Smith RV
Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
[TBL] [Abstract][Full Text] [Related]
2. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
Sibley DR; Weinberger S; Segal DS; Creese I
Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
[No Abstract] [Full Text] [Related]
3. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
Neve KA; Altar CA; Wong CA; Marshall JF
Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
[TBL] [Abstract][Full Text] [Related]
4. Chronic administration of D-amphetamine increases [3H]spiroperidol binding in cat brain.
Trulson ME; Crisp T
Eur J Pharmacol; 1985 Nov; 117(2):267-70. PubMed ID: 4076345
[TBL] [Abstract][Full Text] [Related]
5. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
Ritzmann RF; Lee JM; Fields JZ
Life Sci; 1982 May; 30(18):1573-80. PubMed ID: 7200563
[No Abstract] [Full Text] [Related]
6. Increased sensitivity to dopamine agonists following a single dose of morphine or levorphanol in mice.
Martin JR; Takemori AE
Eur J Pharmacol; 1985 Dec; 119(1-2):75-84. PubMed ID: 3002820
[TBL] [Abstract][Full Text] [Related]
7. Chronic dihydroergotoxine treatment affects the number of dopamine recognition sites in rat striatum.
Battaini F; Govoni S; Rius RA; Spano PF; Trabucchi M
Pharmacol Res Commun; 1984 Jun; 16(6):605-11. PubMed ID: 6463097
[TBL] [Abstract][Full Text] [Related]
8. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems.
Robertson HA
Brain Res; 1983 May; 267(1):179-82. PubMed ID: 6860944
[TBL] [Abstract][Full Text] [Related]
9. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
Bhargava HN
Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397
[TBL] [Abstract][Full Text] [Related]
10. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
Bhargava HN
Gen Pharmacol; 1983; 14(6):609-14. PubMed ID: 6141122
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of fluphenazine-N-mustard on dopamine binding sites and on behavior induced by apomorphine in supersensitive mice.
Thermos K; Winkler JD; Weiss B
Neuropharmacology; 1987 Oct; 26(10):1473-80. PubMed ID: 3120028
[TBL] [Abstract][Full Text] [Related]
12. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
Creese I; Snyder SH
Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
Lai H; Carino MA; Horita A
Psychopharmacology (Berl); 1981; 75(4):388-90. PubMed ID: 6122233
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
Zahniser NR; Molinoff PB
Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
[TBL] [Abstract][Full Text] [Related]
15. Occupation of dopamine receptors by N-n-propylnorapomorphine or spiperone and acetylcholine levels in the rat striatum.
Korf J; Sebens JB; Flentge F; van der Werf JF
J Neurochem; 1985 Jan; 44(1):314-8. PubMed ID: 3964835
[TBL] [Abstract][Full Text] [Related]
16. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
Leysen JE; Gommeren W
J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
[TBL] [Abstract][Full Text] [Related]
17. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
Globus M; Bannet J; Lerer B; Belmaker RH
Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701
[TBL] [Abstract][Full Text] [Related]
18. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
19. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
[TBL] [Abstract][Full Text] [Related]
20. Behavioral facilitation following chronic administration of N-n-propylnorapomorphine.
Wilcox RE; Riffee WH; Chen PC; Hammett S; Smith RV
Psychopharmacology (Berl); 1980; 72(1):113-5. PubMed ID: 6781003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
